Literature DB >> 11378624

Effect of corticosteroids on nuclear factor-kappaB activation and hemodynamics in late septic shock.

H J van Leeuwen1, T van der Bruggen, B S van Asbeck, F T Boereboom.   

Abstract

OBJECTIVE: To describe the underlying pathophysiologic mechanisms of the effect of corticosteroids in a patient with late septic shock.
DESIGN: Case report.
SETTING: The medical intensive care unit at University Medical Center Utrecht. PATIENT: An 86-yr-old female patient with late septic shock requiring mechanical ventilation and vasopressive agents.
INTERVENTIONS: Administration of hydrocortisone, 300 mg daily.
MEASUREMENTS AND MAIN RESULTS: Within 3 days of corticosteroid treatment, the patient could be weaned of vasopressive agents and mechanical ventilation. Serum C-reactive protein levels normalized. Nuclear factor-kappaB activation in unstimulated and in vitro lipopolysaccharide-stimulated peripheral blood mononuclear cells decreased to background level within 5 days. Repeated functional tests of the hypothalamic-pituitary-adrenal axis were normal.
CONCLUSION: Our data suggest that the pathophysiologic mechanism behind the clinical effects of supraphysiologic doses of corticosteroids in late septic shock is directly related to the inhibition of nuclear factor-kappaB in peripheral blood mononuclear cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11378624     DOI: 10.1097/00003246-200105000-00041

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  13 in total

1.  Immunomodulation in surgical practice.

Authors:  R Andersson; B Andersson; E Andersson; G Eckerwall; M Nordén; B Tingstedt
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

Review 2.  Immune-modulating therapy in acute pancreatitis: fact or fiction.

Authors:  Karolina Akinosoglou; Charalambos Gogos
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

3.  Role of steroids in septic shock: assessment of knowledge, attitudes and practices among intensivists practising in Hyderabad.

Authors:  Deven Juneja; Palepu B Gopal; Rashmi R Satapathy; Ravichandra Raya; Venugopal V Madgundi
Journal:  Indian J Crit Care Med       Date:  2009 Jul-Sep

Review 4.  Treatment of acute pancreatitis: focus on medical care.

Authors:  Roland Andersson; Anna Swärd; Bobby Tingstedt; Daniel Akerberg
Journal:  Drugs       Date:  2009       Impact factor: 9.546

5.  Ficoll-separated mononuclear cells from sepsis patients are contaminated with granulocytes.

Authors:  Erica L T van den Akker; Carla C Baan; Bart van den Berg; Henk Russcher; Koen Joosten; Anita C S Hokken-Koelega; Steven W J Lamberts; Jan W Koper
Journal:  Intensive Care Med       Date:  2008-01-08       Impact factor: 17.440

6.  Corticosteroids for Septic Shock: Another Chapter in the Saga.

Authors:  Jason Yerke; Kyle Strnad; Seth R Bauer
Journal:  Hosp Pharm       Date:  2019-02-09

7.  Corticosteroids for severe sepsis: an evidence-based guide for physicians.

Authors:  Djillali Annane
Journal:  Ann Intensive Care       Date:  2011-04-13       Impact factor: 6.925

8.  Does cardiac surgery in newborn infants compromise blood cell reactivity to endotoxin?

Authors:  Kathrin Schumacher; Stefanie Korr; Jaime F Vazquez-Jimenez; Götz von Bernuth; Jean Duchateau; Marie-Christine Seghaye
Journal:  Crit Care       Date:  2005-08-09       Impact factor: 9.097

9.  Corticosteroid therapy in refractory shock following cardiac arrest: a randomized, double-blind, placebo-controlled, trial.

Authors:  Michael W Donnino; Lars W Andersen; Katherine M Berg; Maureen Chase; Robert Sherwin; Howard Smithline; Erin Carney; Long Ngo; Parth V Patel; Xiaowen Liu; Donald Cutlip; Peter Zimetbaum; Michael N Cocchi
Journal:  Crit Care       Date:  2016-04-03       Impact factor: 9.097

10.  Expression of the NF-kappaB inhibitor ABIN-3 in response to TNF and toll-like receptor 4 stimulation is itself regulated by NF-kappaB.

Authors:  Lynn Verstrepen; Minou Adib-Conquy; Marja Kreike; Isabelle Carpentier; Christophe Adrie; Jean-Marc Cavaillon; Rudi Beyaert
Journal:  J Cell Mol Med       Date:  2007-12-10       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.